Your session is about to expire
← Back to Search
Behavioural Intervention
Active cTBS for Primary Insomnia
N/A
Recruiting
Led By William D Killgore, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Greater than or equal to 11 for ESS (Johns, 2000)
Healthy men and non-pregnant, non-lactating women 18-50 (inclusive) years of age, free from contraindicated diseases, medications, devices, and conditions.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the morning cognitive testing on overnight visit 2 (day 16)
Awards & highlights
Study Summary
This study is evaluating whether a type of brain stimulation can improve sleep habits in healthy individuals.
Eligible Conditions
- Primary Insomnia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ once during cognitive testing portion of overnight visit 2 (day 15-16), day 16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once during cognitive testing portion of overnight visit 2 (day 15-16), day 16
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of time spent in each sleep stage following administration of active or sham cTBS TMS
Sleep efficiency (SE) following administration of active or sham cTBS TMS - day 8-9
Sleep onset latency (SOL) following administration of active or sham cTBS TMS
+8 moreSecondary outcome measures
Actigraphy
California Verbal Learning Test Third Edition (CVLT-3) - day 15-16
California Verbal Learning Test Third Edition (CVLT-3) - day 8-9
+83 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Sham cTBS first, then active cTBSExperimental Treatment2 Interventions
Participants complete an Enrollment Visit followed by one week of at-home actigraphy. Participants return to the lab for Overnight Visit 1 and undergo a MRI scan followed by sham cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep. Participants return home and complete another week of at-home actigraphy. Participants then return to the lab for Overnight Visit 2 where they undergo a MRI scan followed by active cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep.
Group II: Active cTBS first, then sham cTBSExperimental Treatment2 Interventions
Participants complete an Enrollment Visit followed by one week of at-home actigraphy. Participants return to the lab for Overnight Visit 1 and undergo a MRI scan followed by active cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep. Participants return home and complete another week of at-home actigraphy. Participants then return to the lab for Overnight Visit 2 where they undergo a MRI scan followed by sham cTBS and then another MRI scan followed by a night of polysomnographic monitored in-lab sleep.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sham cTBS
2016
Completed Phase 2
~220
Find a Location
Who is running the clinical trial?
University of ArizonaLead Sponsor
511 Previous Clinical Trials
148,268 Total Patients Enrolled
William D Killgore, PhDPrincipal InvestigatorUniversity of Arizona
3 Previous Clinical Trials
150 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger